Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-04 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +127,345 127,345
2022-03-04 Shani Eli EVP,Global Marketing&Portfolio Option exercise +3,173 12,264
2022-03-04 Shani Eli EVP,Global Marketing&Portfolio Option exercise · Restricted Share Units −3,173 3,173
2022-03-04 Shani Eli EVP,Global Marketing&Portfolio Grant or award · Restricted Share Units +80,428 80,428
2022-03-04 Schultz Kare President and CEO Option exercise +59,701 1,192,197
2022-03-04 Schultz Kare President and CEO Option exercise +162,593 1,354,790
2022-03-04 Schultz Kare President and CEO Option exercise · Restricted Share Units −59,701 59,702
2022-03-04 Schultz Kare President and CEO Option exercise · Restricted Share Units −162,593 0
2022-03-04 Schultz Kare President and CEO Grant or award · Restricted Share Units +402,144 402,144
2022-03-04 Sabag Mark EVP, International Markets Option exercise +15,920 110,523
2022-03-04 Sabag Mark EVP, International Markets Option exercise +43,358 153,881
2022-03-04 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −15,920 15,921
2022-03-04 Sabag Mark EVP, International Markets Option exercise · Restricted Share Units −43,358 0
2022-03-04 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +134,048 134,048
2022-03-04 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +134,048 134,048
2022-03-04 Inbar Galia See "Remarks" Grant or award · Restricted Share Units +80,428 80,428
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +51,488 116,996.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −18,020 $7.48 $135K 98,976.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +18,905 117,881.51
2022-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −6,618 $7.48 $50K 111,263.51

Page 38 of 76 · 1,517 trades